Company profile: Catalog
1.1 - Company Overview
Company description
- Provider of a data conversion and storage platform used to offer next-generation digital data archives.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Catalog
Gnubio
HQ: United States
Website
- Description: Provider of scalable desktop DNA sequencing systems for diagnostic and applied markets, integrating target selection, DNA amplification, sequencing, and analysis via emulsion-based droplet microfluidics. Offers single-use consumable cartridges and workflows for targeted sequencing and hotspot analysis, with whole genome and transcriptome applications in development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gnubio company profile →
Qiagen
HQ: The Netherlands
Website
- Description: Provider of technologies and products for preanalytical sample preparation and linked molecular assay solutions. Supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics, with sample and assay consumables offered in kit form. Portfolio includes automated nucleic acid purification systems, sample disruption tools, real-time and digital PCR platforms, and automated PCR setup.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qiagen company profile →
Vector BioMed
HQ: United States
Website
- Description: Provider of state-of-the-art custom vector design and GMP manufacturing, specializing in Lentiviral vector production for research, pre-clinical, IND-enabling, and clinical trials using a serum-free, chemically-defined process; algorithm-based vector design optimized for titer, transduction, and transgene expression; custom assay development; and support services for clinical development and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vector BioMed company profile →
Orna Therapeutics
HQ: United States
Website
- Description: Provider of engineered circular RNA therapeutics and tools: isCAR therapy using oRNA and proprietary LNPs to modify immune cells for tumor control without lymphodepletion; oRNA-based dystrophin replacement via non-viral delivery to liver and muscle; next-generation vaccines with Merck using oRNA/LNP; and FoRCE for high-throughput oRNA sequence evaluation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Orna Therapeutics company profile →
EpiBiome
HQ: United States
Website
- Description: Provider of precision microbiome engineering focused on developing alternatives to small-molecule antibiotics for use in healthcare, veterinary, and agriculture industries to address antibiotic resistance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EpiBiome company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Catalog
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Catalog
2.2 - Growth funds investing in similar companies to Catalog
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Catalog
4.2 - Public trading comparable groups for Catalog
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →